Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Electronic prescribing

Pilot of EPS controlled drugs prescribing due to begin

A pilot of prescribing schedule 2 and 3 controlled drugs using the electronic prescription service (EPS) is beginning soon, the Pharmaceutical Services Negotiating Committee (PSNC) has said.

Initially, up to 15 GP practices in two areas of England — London and the North West — will take part before the change is rolled out nationally.

“We welcome this development as it takes the sector one step closer to a fully streamlined EPS process, which will avoid the current challenge of some patients requiring both EPS and paper prescriptions,” said Alastair Buxton, director of NHS services at the PSNC.

Regulations were amended in 2015 to allow schedule 2 and 3 controlled drugs to be prescribed and dispensed via EPS but this has not yet been implemented due to technical reasons. The pilot is intended to demonstrate that IT systems and pharmacy processes are capable.

The PSNC said that pharmacies local to practices taking part in the pilot will be informed nearer the time once NHS Digital has confirmed the start date but that all community pharmacy teams should be aware it is taking place, as patients can choose where to have their prescription dispensed.

The PSNC said that standard operating procedures can be changed to reflect that schedule 2 and 3 controlled drugs could be prescribed via the EPS or by FP10 paper. Pharmacies may also need to change their procedures if they do not allow for controlled drugs and non-controlled drugs to be dealt with on the same prescription.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2017.20203687

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Drugs of Abuse

    Drugs of Abuse

    A concise, easy-to-read guide for healthcare professionals who encounter drug abuse.

    £38.00Buy now
  • Pharmaceutical Toxicology

    Pharmaceutical Toxicology

    Explains the methodology and requirements of pre-clinical safety assessments of new medicines. Includes registration requirements and pharmacovigilance.

    £40.00Buy now
  • Prescribing Adult Intravenous Nutrition

    Prescribing Adult Intravenous Nutrition

    A practical guide to the principles and practice of adult intravenous nutrition. With numerous illustrations and case studies.

    £40.00Buy now
  • Drugs and the Liver

    Drugs and the Liver

    Drugs and the Liver assists practitioners in making pragmatic choices for their patients. It enables you to assess liver function and covers the principles of drug use in liver disease.

    £38.00Buy now
  • Clarke's Analysis of Drugs and Poisons

    Clarke's Analysis of Drugs and Poisons

    Clarke's Analysis of Drugs and Poisons is the definitive reference source of analytical data for drugs and poisons.

    £535.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • alastair buxton

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.